IDEXX Laboratories, Inc. (IDXX) key performance indicators and operating metrics (9 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| CAG Diagnostics recurring revenue growth - International (reported) | 20.00 percent | FY2026-Q1 |
| Reference laboratory diagnostic and consulting services revenue growth (reported) | 12.00 percent | FY2026-Q1 |
| IDEXX InViewDx placements | 1.1K | FY2026-Q1 |
| Water revenue growth (reported) | 12.00 percent | FY2025-Q4 |
| CAG revenue growth (reported) | 15.00 percent | FY2025-Q4 |
| LPD revenue growth (reported) | 8.00 percent | FY2025-Q4 |
| CAG Diagnostics recurring revenue growth (reported) | 11.00 percent | FY2025-Q3 |
| CAG Diagnostics recurring revenue growth (organic) | 10.00 percent | FY2025-Q3 |
| Revenue growth (reported) | 13.00 percent | FY2025-Q3 |
Back to IDXX overview · IDXX earnings · IDXX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.